Cell and Tissue Preservation Market Size, Share, Trends, Growth Outlook

Cell and Tissue Preservation Market is estimated to increase at a growth rate of 11.1% CAGR over the forecast period from 2024 to 2030.

The Cell and Tissue Preservation Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Preservation Technique (Cryopreservation, Hypothermic Preservation), By Product (Equipment and Consumables, Laboratory Information Management Systems (LIMS), Accessories (vials, containers, labels), By Application (Organ Transplantation:, Regenerative Medicine, Biobanking, Drug Discovery and Development), By End-User (Hospitals and Transplant Centers, Biobanks and Research Institutes, Pharmaceutical and Biotechnology Companies, Cell and Tissue Banks, Others).

An Introduction to Cell and Tissue Preservation Market in 2024

The Cell and Tissue Preservation market in 2024 serves the needs of biobanking facilities, research laboratories, and healthcare institutions in preserving cells and tissues for research, transplantation, and regenerative medicine applications. Preservation methods include cryopreservation, chemical fixation, and hypothermic storage, aiming to maintain cellular viability, integrity, and functionality over extended periods. Market dynamics are driven by factors such as the increasing demand for biobanking and personalized medicine, advancements in preservation technologies, and the need to optimize sample quality and stability. Collaboration between biobanking facilities, tissue banks, medical device manufacturers, and regulatory agencies drives innovation and market expansion in cell and tissue preservation solutions, ensuring the availability of high-quality biological samples for research and clinical applications.

Cell and Tissue Preservation Market Trend: Growing Emphasis on Cryopreservation Technologies

A prominent trend in the Cell and Tissue Preservation market is the growing emphasis on cryopreservation technologies. With the increasing demand for long-term storage of cells and tissues for research, clinical applications, and regenerative medicine, there is a rising adoption of cryopreservation methods to maintain cell viability and functionality over extended periods. Cryopreservation techniques, such as vitrification and controlled-rate freezing, offer advantages in preserving cellular integrity and viability, thereby driving their adoption across various fields, including stem cell research, organ transplantation, and cell-based therapies.

Cell and Tissue Preservation Market Driver: Expanding Applications in Regenerative Medicine and Biobanking

The primary driver for the Cell and Tissue Preservation market is the expanding applications in regenerative medicine and biobanking. As the field of regenerative medicine continues to advance, there is a growing need for reliable methods to preserve cells and tissues for transplantation, tissue engineering, and cell-based therapies. Additionally, the establishment of biobanks for the storage of human biological samples, including cells, tissues, and organs, for research and clinical purposes further fuels the demand for preservation technologies. These applications drive the adoption of advanced preservation techniques and drive market growth.

Cell and Tissue Preservation Market Opportunity: Development of Novel Preservation Solutions and Devices

An opportunity in the Cell and Tissue Preservation market lies in the development of novel preservation solutions and devices. With the increasing demand for improved preservation outcomes, there is a need for innovative technologies that offer enhanced efficiency, scalability, and compatibility with diverse cell and tissue types. Companies involved in the development of preservation solutions and devices can capitalize on this opportunity by investing in research and development to create next-generation products with improved performance, such as novel cryoprotectants, automated cryopreservation systems, and point-of-care preservation devices. By addressing unmet needs and providing solutions that enhance preservation efficacy and convenience, manufacturers can capture a significant share of the growing market.

Cell and Tissue Preservation Market Segmentation

By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Cell and Tissue Preservation Market Companies

Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC

 

 

Reasons to Buy the Cell and Tissue Preservation Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cell and Tissue Preservation Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cell and Tissue Preservation Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Cell and Tissue Preservation Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cell and Tissue Preservation Market Size Outlook, $ Million, 2021 to 2030
3.2 Cell and Tissue Preservation Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cell and Tissue Preservation Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cell and Tissue Preservation Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cell and Tissue Preservation Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cell and Tissue Preservation Market Industry
4.2 Key Market Trends in Cell and Tissue Preservation Market Industry
4.3 Potential Opportunities in Cell and Tissue Preservation Market Industry
4.4 Key Challenges in Cell and Tissue Preservation Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Cell and Tissue Preservation Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cell and Tissue Preservation Market Outlook By Segments
7.1 Cell and Tissue Preservation Market Outlook by Segments
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

8 North America Cell and Tissue Preservation Market Analysis And Outlook To 2030
8.1 Introduction to North America Cell and Tissue Preservation Markets in 2024
8.2 North America Cell and Tissue Preservation Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cell and Tissue Preservation Market size Outlook by Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

9 Europe Cell and Tissue Preservation Market Analysis And Outlook To 2030
9.1 Introduction to Europe Cell and Tissue Preservation Markets in 2024
9.2 Europe Cell and Tissue Preservation Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cell and Tissue Preservation Market Size Outlook By Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

10 Asia Pacific Cell and Tissue Preservation Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Cell and Tissue Preservation Markets in 2024
10.2 Asia Pacific Cell and Tissue Preservation Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cell and Tissue Preservation Market size Outlook by Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

11 South America Cell and Tissue Preservation Market Analysis And Outlook To 2030
11.1 Introduction to South America Cell and Tissue Preservation Markets in 2024
11.2 South America Cell and Tissue Preservation Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cell and Tissue Preservation Market size Outlook by Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

12 Middle East And Africa Cell and Tissue Preservation Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Cell and Tissue Preservation Markets in 2024
12.2 Middle East and Africa Cell and Tissue Preservation Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cell and Tissue Preservation Market size Outlook by Segments, 2021-2030
By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Avantor Inc
BioLife Solutions Inc
Cesca Therapeutics Inc
Chart Industries Inc
Custom Biogenic Systems
GE Healthcare
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific Inc
VWR International LLC

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Preservation Technique
Cryopreservation
-Equipment (freezers, storage systems)
-Consumables (cryopreservation media, cryoprotectants)
Hypothermic Preservation
-Organ preservation solutions
-Cold storage systems
By Product Type
Equipment and Consumables
-Freezers and storage systems
-Cryopreservation media and solutions
-Cryoprotectants
-Hypothermic preservation solutions
-Organ preservation solutions
Laboratory Information Management Systems (LIMS)
Accessories (vials, containers, labels)
By Application
Organ Transplantation:
-Solid organs (heart, kidney, liver, lung, etc.)
-Soft tissues (cornea, skin, bone, etc.)
Regenerative Medicine
-Stem cell preservation
-Tissue engineering
-Cell-based therapies
Biobanking
-Storage of biological samples for research and diagnostics
Drug Discovery and Development
-Preservation of cells and tissues for drug screening and testing
By End User
Hospitals and Transplant Centers
Biobanks and Research Institutes
Pharmaceutical and Biotechnology Companies
Cell and Tissue Banks
Others